Bio-Rad Laboratories, Inc. Share Price NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298.50 USD | +1.75% |
|
+0.68% | -3.93% |
| 01/07 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 03/06 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 793.65Cr 694.2Cr 640.31Cr 591.39Cr 1.12TCr 76TCr 1.14TCr 7.65TCr 3TCr 37TCr 2.98TCr 2.92TCr 1,28200Cr | P/E 2026 * |
35.6x | P/E 2027 * | 34.8x |
|---|---|---|---|---|---|
| Enterprise Value | 718.75Cr 628.69Cr 579.88Cr 535.58Cr 1.02TCr 69TCr 1.03TCr 6.93TCr 2.72TCr 34TCr 2.7TCr 2.64TCr 1,16100Cr | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.65x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +1.75% | ||
| 1 week | +0.68% | ||
| Current month | +0.68% | ||
| 1 month | -1.86% | ||
| 3 months | +7.76% | ||
| 6 months | -3.93% | ||
| Current year | -3.93% |
| 1 week | 293.37 |  | 298.5 |
| 1 month | 289.23 | | 298.5 |
| Current year | 244.54 | | 312.75 |
| 1 year | 244.54 | | 321.12 |
| 3 years | 0 | | 387.55 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.75% | +0.68% | - | - | 793.65Cr | |
| -0.50% | -1.54% | -28.85% | -12.62% | 16TCr | |
| +1.80% | +0.82% | -6.73% | -3.92% | 11TCr | |
| +0.32% | +2.34% | +2.79% | +57.04% | 5.9TCr | |
| +0.79% | -3.68% | +39.99% | +54.50% | 5.17TCr | |
| +0.72% | -3.88% | -13.66% | -41.41% | 4.19TCr | |
| +0.47% | -4.98% | - | - | 3.47TCr | |
| +2.66% | +5.21% | -10.09% | -42.88% | 2.89TCr | |
| -1.10% | -3.29% | +55.70% | -5.76% | 2.5TCr | |
| 0.00% | -1.01% | -5.28% | -3.57% | 2.11TCr | |
| Average | +0.69% | -1.03% | +4.23% | +0.17% | 5.93TCr | |
| Weighted average by Cap. | +0.52% | -0.93% | -5.60% | +1.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 256.72Cr 224.55Cr 207.12Cr 191.3Cr 362.98Cr 24TCr 369.08Cr 2.47TCr 971.83Cr 12TCr 963.9Cr 942.92Cr 41TCr | 263.48Cr 230.47Cr 212.58Cr 196.33Cr 372.54Cr 25TCr 378.8Cr 2.54TCr 997.43Cr 12TCr 989.29Cr 967.76Cr 43TCr |
| Net income | 22Cr 20Cr 18Cr 17Cr 32Cr 2.14TCr 32Cr 216.75Cr 85Cr 1.06TCr 84Cr 83Cr 3.63TCr | 23Cr 20Cr 19Cr 17Cr 32Cr 2.19TCr 33Cr 221.44Cr 87Cr 1.08TCr 86Cr 84Cr 3.71TCr |
| Net Debt | -75Cr -66Cr -60Cr -56Cr -105.91Cr -7.14TCr -107.69Cr -722.04Cr -283.55Cr -3.52TCr -281.23Cr -275.11Cr -12TCr | -97Cr -84Cr -78Cr -72Cr -136.5Cr -9.21TCr -138.8Cr -930.65Cr -365.47Cr -4.54TCr -362.49Cr -354.6Cr -16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $298.50 | +1.75% | 57 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
